Therapeutic analysis of cannabidiol for Alzheimer treatment

Detalhes bibliográficos
Autor(a) principal: Magalhães, Maria Vitória Frota
Data de Publicação: 2024
Outros Autores: Nogueira , Ruymara Candal, Bertazzon, Joana Baschung, Vicente, Andressa Gonçalves, Sereno, Marcos Gabriel Bastos, Palhares, Carlos Vinícius Teixeira, Silva, Marina Rodrigues e
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/45006
Resumo: Objective: To analyze therapeutic evidence regarding the potential antioxidant, anti-inflammatory and neuroprotective effects of cannabidiol (CBD) and its effectiveness for the treatment of Alzheimer's Disease (AD). Methodology: Data collection, in the Virtual Health Library, targeting the primary databases Medical Literature Analysis and Retrieval System Online (Medline) and Latin American and Caribbean Literature in Health Sciences (Lilacs) to answer the research question: is the therapeutic use of cannabidiol effective in improving the treatment of patients with Alzheimer's Disease? Results: 14 articles were selected, after analyzing the inclusion and exclusion criteria, all after 2017, with the largest number concentrating on systematic literature review or meta-analysis. Conclusion: Cannabidiol has clear potential to reduce the symptoms of AD given its action on the Central Nervous System. Therefore, its therapeutic use in the treatment of AD emerges as a promising field of investigation, highlighting its relevance as a safe and effective treatment option. Therefore, an in-depth understanding of the antioxidant, anti-inflammatory and neuroprotective properties of CBD is necessary, not only for a better clinical definition of AD, but also for a series of neurological diseases that still have undefined treatments. The potential of CBD, therefore, represents a valuable alternative in the context of neurology, offering significant perspectives for the treatment of neurodegenerative conditions.
id UNIFEI_453d2adb4f9f95c7a8c607b9c6350519
oai_identifier_str oai:ojs.pkp.sfu.ca:article/45006
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Therapeutic analysis of cannabidiol for Alzheimer treatmentAnálisis terapéutico del cannabidiol para el tratamiento de AlzheimerAnálise terapêutica do canabidiol para o tratamento de AlzheimerEnfermedad de AlzheimerTerapéuticoCannabidiolTratamiento.Alzheimer diseaseTherapeuticCannabidiolTreatment.Doença de AlzheimerTerapêuticoCanabidiolTratamento.Objective: To analyze therapeutic evidence regarding the potential antioxidant, anti-inflammatory and neuroprotective effects of cannabidiol (CBD) and its effectiveness for the treatment of Alzheimer's Disease (AD). Methodology: Data collection, in the Virtual Health Library, targeting the primary databases Medical Literature Analysis and Retrieval System Online (Medline) and Latin American and Caribbean Literature in Health Sciences (Lilacs) to answer the research question: is the therapeutic use of cannabidiol effective in improving the treatment of patients with Alzheimer's Disease? Results: 14 articles were selected, after analyzing the inclusion and exclusion criteria, all after 2017, with the largest number concentrating on systematic literature review or meta-analysis. Conclusion: Cannabidiol has clear potential to reduce the symptoms of AD given its action on the Central Nervous System. Therefore, its therapeutic use in the treatment of AD emerges as a promising field of investigation, highlighting its relevance as a safe and effective treatment option. Therefore, an in-depth understanding of the antioxidant, anti-inflammatory and neuroprotective properties of CBD is necessary, not only for a better clinical definition of AD, but also for a series of neurological diseases that still have undefined treatments. The potential of CBD, therefore, represents a valuable alternative in the context of neurology, offering significant perspectives for the treatment of neurodegenerative conditions.Objetivo: Analizar la evidencia terapéutica sobre los potenciales efectos antioxidantes, antiinflamatorios y neuroprotectores del cannabidiol (CBD) y su efectividad para el tratamiento de la Enfermedad de Alzheimer (EA). Metodología: Recolección de datos, en la Biblioteca Virtual en Salud, dirigidos a las bases de datos primarias Medical Literature Analysis and Retrieval System Online (Medline) y Literatura Latinoamericana y del Caribe en Ciencias de la Salud (Lilacs) para responder a la pregunta de investigación: ¿es efectivo el uso terapéutico del cannabidiol para mejorar el tratamiento de pacientes con Enfermedad de Alzheimer? Resultados: Se seleccionaron 14 artículos, luego de analizar los criterios de inclusión y exclusión, todos posteriores a 2017, concentrándose el mayor número en revisión sistemática de literatura o metanálisis. Conclusión: El cannabidiol tiene un claro potencial para reducir los síntomas de la EA dada su acción sobre el Sistema Nervioso Central. Por tanto, su uso terapéutico en el tratamiento de la EA emerge como un campo de investigación prometedor, destacando su relevancia como una opción de tratamiento segura y eficaz. Por tanto, es necesario un conocimiento profundo de las propiedades antioxidantes, antiinflamatorias y neuroprotectoras del CBD, no sólo para una mejor definición clínica de la EA, sino también de una serie de enfermedades neurológicas que aún tienen tratamientos indefinidos. El potencial del CBD, por tanto, representa una alternativa valiosa en el contexto de la neurología, ofreciendo importantes perspectivas para el tratamiento de enfermedades neurodegenerativas.Objetivo: Analisar as evidências terapêuticas quanto aos potenciais efeitos antioxidantes, anti-inflamatórios e neuroprotetores do canabidiol (CDB) e sua eficácia para o tratamento da Doença de Alzheimer (DA). Metodologia: Levantamento de dados, na Biblioteca Virtual em Saúde, com direcionamento às bases primárias Medical Literature Analysis and Retrieval System Online (Medline) e Literatura Latino-Americana e do Caribe em Ciências da Saúde (Lilacs) para responder à pergunta de pesquisa: o uso terapêutico do canabidiol é eficaz para melhorar o tratamento de pacientes com Doença de Alzheimer? Resultados: Foram selecionados 14 artigos, após análise dos critérios de inclusão e exclusão, todos posteriores ao ano de 2017, concentrando-se o maior número em revisão sistemática da literatura ou metanálise. Conclusão: O canabidiol possui potencial evidente para diminuir a sintomatologia da DA tendo em vista sua atuação no Sistema Nervoso Central. Desta forma, seu uso terapêutico no tratamento de DA emerge como um campo de investigação promissor, destacando sua relevância como uma opção de tratamento seguro e efetivo. Portanto, faz-se necessária a compreensão aprofundada das propriedades antioxidantes, anti-inflamatórias e neuroprotetoras do CBD, não apenas para a melhor definição clínica da DA, mas também para uma série de doenças neurológicas que ainda possuem tratamentos indefinidos. O potencial do CBD, assim, representa uma valiosa alternativa no contexto da neurologia, oferecendo perspectivas significativas para o tratamento de condições neurodegenerativas.Research, Society and Development2024-02-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4500610.33448/rsd-v13i2.45006Research, Society and Development; Vol. 13 No. 2; e6513245006Research, Society and Development; Vol. 13 Núm. 2; e6513245006Research, Society and Development; v. 13 n. 2; e65132450062525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/45006/35947Copyright (c) 2024 Maria Vitória Frota Magalhães; Ruymara Candal Nogueira ; Joana Baschung Bertazzon; Andressa Gonçalves Vicente; Marcos Gabriel Bastos Sereno; Carlos Vinícius Teixeira Palhares; Marina Rodrigues e Silvahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMagalhães, Maria Vitória Frota Nogueira , Ruymara Candal Bertazzon, Joana Baschung Vicente, Andressa Gonçalves Sereno, Marcos Gabriel Bastos Palhares, Carlos Vinícius Teixeira Silva, Marina Rodrigues e 2024-03-04T09:47:20Zoai:ojs.pkp.sfu.ca:article/45006Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-03-04T09:47:20Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Therapeutic analysis of cannabidiol for Alzheimer treatment
Análisis terapéutico del cannabidiol para el tratamiento de Alzheimer
Análise terapêutica do canabidiol para o tratamento de Alzheimer
title Therapeutic analysis of cannabidiol for Alzheimer treatment
spellingShingle Therapeutic analysis of cannabidiol for Alzheimer treatment
Magalhães, Maria Vitória Frota
Enfermedad de Alzheimer
Terapéutico
Cannabidiol
Tratamiento.
Alzheimer disease
Therapeutic
Cannabidiol
Treatment.
Doença de Alzheimer
Terapêutico
Canabidiol
Tratamento.
title_short Therapeutic analysis of cannabidiol for Alzheimer treatment
title_full Therapeutic analysis of cannabidiol for Alzheimer treatment
title_fullStr Therapeutic analysis of cannabidiol for Alzheimer treatment
title_full_unstemmed Therapeutic analysis of cannabidiol for Alzheimer treatment
title_sort Therapeutic analysis of cannabidiol for Alzheimer treatment
author Magalhães, Maria Vitória Frota
author_facet Magalhães, Maria Vitória Frota
Nogueira , Ruymara Candal
Bertazzon, Joana Baschung
Vicente, Andressa Gonçalves
Sereno, Marcos Gabriel Bastos
Palhares, Carlos Vinícius Teixeira
Silva, Marina Rodrigues e
author_role author
author2 Nogueira , Ruymara Candal
Bertazzon, Joana Baschung
Vicente, Andressa Gonçalves
Sereno, Marcos Gabriel Bastos
Palhares, Carlos Vinícius Teixeira
Silva, Marina Rodrigues e
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Magalhães, Maria Vitória Frota
Nogueira , Ruymara Candal
Bertazzon, Joana Baschung
Vicente, Andressa Gonçalves
Sereno, Marcos Gabriel Bastos
Palhares, Carlos Vinícius Teixeira
Silva, Marina Rodrigues e
dc.subject.por.fl_str_mv Enfermedad de Alzheimer
Terapéutico
Cannabidiol
Tratamiento.
Alzheimer disease
Therapeutic
Cannabidiol
Treatment.
Doença de Alzheimer
Terapêutico
Canabidiol
Tratamento.
topic Enfermedad de Alzheimer
Terapéutico
Cannabidiol
Tratamiento.
Alzheimer disease
Therapeutic
Cannabidiol
Treatment.
Doença de Alzheimer
Terapêutico
Canabidiol
Tratamento.
description Objective: To analyze therapeutic evidence regarding the potential antioxidant, anti-inflammatory and neuroprotective effects of cannabidiol (CBD) and its effectiveness for the treatment of Alzheimer's Disease (AD). Methodology: Data collection, in the Virtual Health Library, targeting the primary databases Medical Literature Analysis and Retrieval System Online (Medline) and Latin American and Caribbean Literature in Health Sciences (Lilacs) to answer the research question: is the therapeutic use of cannabidiol effective in improving the treatment of patients with Alzheimer's Disease? Results: 14 articles were selected, after analyzing the inclusion and exclusion criteria, all after 2017, with the largest number concentrating on systematic literature review or meta-analysis. Conclusion: Cannabidiol has clear potential to reduce the symptoms of AD given its action on the Central Nervous System. Therefore, its therapeutic use in the treatment of AD emerges as a promising field of investigation, highlighting its relevance as a safe and effective treatment option. Therefore, an in-depth understanding of the antioxidant, anti-inflammatory and neuroprotective properties of CBD is necessary, not only for a better clinical definition of AD, but also for a series of neurological diseases that still have undefined treatments. The potential of CBD, therefore, represents a valuable alternative in the context of neurology, offering significant perspectives for the treatment of neurodegenerative conditions.
publishDate 2024
dc.date.none.fl_str_mv 2024-02-17
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/45006
10.33448/rsd-v13i2.45006
url https://rsdjournal.org/index.php/rsd/article/view/45006
identifier_str_mv 10.33448/rsd-v13i2.45006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/45006/35947
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 13 No. 2; e6513245006
Research, Society and Development; Vol. 13 Núm. 2; e6513245006
Research, Society and Development; v. 13 n. 2; e6513245006
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052638104125440